BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

July 21, 2022

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

July 7, 2022

BioSig Announces Closing of Public Offering of Common Stock

June 29, 2022

BioSig Announces Pricing of Public Offering of Common Stock

June 24, 2022

BioSig Announces Proposed Public Offering of Common Stock

June 23, 2022

BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic

June 22, 2022

BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide

May 26, 2022

BioSig’s PURE EP™ System to be Featured During EPLive 2022

May 25, 2022

BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements

May 11, 2022

BioSig to Present at Heart Rhythm 2022

April 19, 2022